Skip to main
TNDM

TNDM Stock Forecast & Price Target

TNDM Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 22%
Buy 28%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Tandem Diabetes Care is well positioned with multiple innovative products, including t:slim X2, Mobi, and Sigi tubeless patch pump. The company has a strong potential for growth with its multi-year runway, high demand for its products in both Type 1 and Type 2 markets, and its target market of 11 million people with diabetes. Its recent shift to the pharmacy channel is also expected to drive growth and profitability.

Bears say

Tandem Diabetes Care is facing several risks, including potential competition from other companies and challenges in retaining its customer base. Despite its recent success in introducing new products, uncertainties remain in its ability to expand in both domestic and international markets. Additionally, its dependence on third-party suppliers and the potential negative impact of reimbursement issues could impact its financial performance.

TNDM has been analyzed by 18 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 28% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tandem Diabetes Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tandem Diabetes Care (TNDM) Forecast

Analysts have given TNDM a Buy based on their latest research and market trends.

According to 18 analysts, TNDM has a Buy consensus rating as of Sep 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $28.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $28.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tandem Diabetes Care (TNDM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.